In Owasso, Oklahoma, we provide a comprehensive approach by combining effective medications with lifestyle changes to support sustainable weight loss
Notably, the STEP TEENS trial showed that semaglutide 2.4 mg, administered once weekly via subcutaneous injection, can be used in individuals aged 12 years and older, as adolescents with obesity treated with semaglutide experienced a significant reduction in BMI compared with placebo, along with improvements in several cardiometabolic risk factors [47]
It's not just another GLP-1 agonist
and glucagon activity contributes to energy expenditure and hepatic lipid handling
In a large-scale study, most participants who used Semaglutide or Tirzepatide alongside healthy eating and workout routines lost up to 15% of their total body weight, and with a smaller group, shedding as much as 20%